Loading…
Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis
Backoround Hepatocellular carcinoma (HCC) often occurs in association with liver cirrhosis. A stepwise carcinogenesis for HCC has been proposed. The purpose of this study was to observe the enhancement pattern of hepatocellular nodules in cirrhotic patients using contrast-enhanced ultrasound (CEUS)...
Saved in:
Published in: | Chinese medical journal 2012-09, Vol.125 (17), p.3104-3109 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 3109 |
container_issue | 17 |
container_start_page | 3104 |
container_title | Chinese medical journal |
container_volume | 125 |
creator | Wu, Wei Chen, Min-Hua Sun, Maryellen Yan, Kun Yang, Wei Li, Ji-You |
description | Backoround Hepatocellular carcinoma (HCC) often occurs in association with liver cirrhosis. A stepwise carcinogenesis for HCC has been proposed. The purpose of this study was to observe the enhancement pattern of hepatocellular nodules in cirrhotic patients using contrast-enhanced ultrasound (CEUS) and to correlate patterns of enhancement at CEUS with the diagnosis of hepatocellular nodules using pathologic correlation as the gold standard. Methods Ninety-three cirrhotic patients with indeterminate hepatocellular nodules at ultrasound, underwent biopsy of each indeterminate nodule. Patients with nodules found to have pathologic diagnoses of regenerative nodules (RNs), dysplastic nodules (DNs), or DNs with focus of HCC (DN-HCC), were enrolled in this study. Enhancement patterns of all nodules were examined throughout the various vascular phases of CEUS and classified into five enhancement patterns: type I, isoenhancement to hepatic parenchyma at all phases; type II, hypoenhancement in the arterial phase, and isoenhancement in the portal venous phase and late phase; type III, iso-to-hypoenhancement in arterial and portal venous phase, and hypoenhancement in the late phase (washout); type IV, slight hyperenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout); and type V, partial hyperenhancement in the arterial phase and hypoenhancement in the late phase; and another partial iso-to-hypoenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout). The correlation between the contrast enhancement patterns and the pathological diagnoses was analyzed by the chi-squared test. Results Totally 132 lesions were examined with CEUS in 93 patients. Pathologic diagnoses included 45 DN, 68 RN, and 19 DN-HCC. The enhancement patterns observed were as follows: type I, 49 (37.1%); type II, 27 (20.5%); type III, 28 (21.2%); type IV, 9 (6.8%); type V, 19 (14.4%). Nodules with type I enhancement showed dysplasia in 5 (10.2%) cases; nodules with type II were dysplastic in 11 (40.7%) of cases; nodules with type III enhancement pattern were dysplastic in 22 (78.6%), and those with type IV enhancement contained dysplasia in 7 (77.8%) of cases. Type V enhancement corresponded to DN-HCC in 19 (100%) of cases. CEUS enhancement pattern was correlated with likelihood of dysplasia at pathologic analysis (Trend chi-square test, P 〈0.001). Pathological diagnosis was HCC in the enhanced area and hepatocyte d |
doi_str_mv | 10.3760/cma.j.issn.0366-6999.2012.17.025 |
format | article |
fullrecord | <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj201217026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>43197974</cqvip_id><wanfj_id>zhcmj201217026</wanfj_id><sourcerecordid>zhcmj201217026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c268t-fc7797759f2b3e44682c8afe66d8d871325690afba0ee0247f9f041be2f39ba03</originalsourceid><addsrcrecordid>eNo90E1LwzAYB_AgipvTryD1Il5a89akOcrQKQy86LmkabKmrMlMWkU_vRlznh748-N5A-AOwYJwBu_VIIu-sDG6AhLGciaEKDBEuEC8gLg8AXNcUpyXjKJTMP83M3ARYw-TKDk7BzOMBcGoEnOwWno3BhnHXLtOOqXbbNruAz-5NvMm6_ROjl7JoKzzG-10tDGzLtvaTx0yZUPofIouwZmR26iv_uoCvD89vi2f8_Xr6mX5sM4VZtWYG8W54LwUBjdEU8oqrCppNGNt1VYcEVwyAaVpJNQaYsqNMJCiRmNDRArJAtwe-n5JZ6Tb1L2fgksT659ODf3-F4hDzBK8PsDd1Ay6rXfBDjJ818fTE7g5ANV5t_mwqdfRUIJEWpOSX-4xa7E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis</title><source>HEAL-Link subscriptions: Lippincott Williams & Wilkins</source><creator>Wu, Wei ; Chen, Min-Hua ; Sun, Maryellen ; Yan, Kun ; Yang, Wei ; Li, Ji-You</creator><creatorcontrib>Wu, Wei ; Chen, Min-Hua ; Sun, Maryellen ; Yan, Kun ; Yang, Wei ; Li, Ji-You</creatorcontrib><description>Backoround Hepatocellular carcinoma (HCC) often occurs in association with liver cirrhosis. A stepwise carcinogenesis for HCC has been proposed. The purpose of this study was to observe the enhancement pattern of hepatocellular nodules in cirrhotic patients using contrast-enhanced ultrasound (CEUS) and to correlate patterns of enhancement at CEUS with the diagnosis of hepatocellular nodules using pathologic correlation as the gold standard. Methods Ninety-three cirrhotic patients with indeterminate hepatocellular nodules at ultrasound, underwent biopsy of each indeterminate nodule. Patients with nodules found to have pathologic diagnoses of regenerative nodules (RNs), dysplastic nodules (DNs), or DNs with focus of HCC (DN-HCC), were enrolled in this study. Enhancement patterns of all nodules were examined throughout the various vascular phases of CEUS and classified into five enhancement patterns: type I, isoenhancement to hepatic parenchyma at all phases; type II, hypoenhancement in the arterial phase, and isoenhancement in the portal venous phase and late phase; type III, iso-to-hypoenhancement in arterial and portal venous phase, and hypoenhancement in the late phase (washout); type IV, slight hyperenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout); and type V, partial hyperenhancement in the arterial phase and hypoenhancement in the late phase; and another partial iso-to-hypoenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout). The correlation between the contrast enhancement patterns and the pathological diagnoses was analyzed by the chi-squared test. Results Totally 132 lesions were examined with CEUS in 93 patients. Pathologic diagnoses included 45 DN, 68 RN, and 19 DN-HCC. The enhancement patterns observed were as follows: type I, 49 (37.1%); type II, 27 (20.5%); type III, 28 (21.2%); type IV, 9 (6.8%); type V, 19 (14.4%). Nodules with type I enhancement showed dysplasia in 5 (10.2%) cases; nodules with type II were dysplastic in 11 (40.7%) of cases; nodules with type III enhancement pattern were dysplastic in 22 (78.6%), and those with type IV enhancement contained dysplasia in 7 (77.8%) of cases. Type V enhancement corresponded to DN-HCC in 19 (100%) of cases. CEUS enhancement pattern was correlated with likelihood of dysplasia at pathologic analysis (Trend chi-square test, P 〈0.001). Pathological diagnosis was HCC in the enhanced area and hepatocyte dysplasia in the un-enhanced area in the 19 DN-HCC. Conclusion Pattern of enhancement at CEUS correlates with the pathologic diagnosis of hepatocellular nodules in liver cirrhosis, and may be helpful in predicting the progress from RN to HCC nodules.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.3760/cma.j.issn.0366-6999.2012.17.025</identifier><identifier>PMID: 22932189</identifier><language>eng</language><publisher>China: Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Ultrasound,Peking University Cancer Hospital & Institute,Beijing 100142,China%Abdominal Imaging,Department of Radiology,Beth Israel Deaconess Medical Center,Boston,02215,USA%Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Pathology,Peking University Cancer Hospital & Institute,Beijing 100142,China</publisher><subject>Adult ; Aged ; Carcinoma, Hepatocellular - diagnostic imaging ; Carcinoma, Hepatocellular - pathology ; Contrast Media ; Female ; Humans ; Image Enhancement ; Liver Cirrhosis - complications ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - pathology ; Male ; Middle Aged ; Ultrasonography ; 卡方检验 ; 增生性 ; 病理诊断 ; 肝癌 ; 肝硬化 ; 肝细胞癌 ; 超声 ; 造影</subject><ispartof>Chinese medical journal, 2012-09, Vol.125 (17), p.3104-3109</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22932189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Wei</creatorcontrib><creatorcontrib>Chen, Min-Hua</creatorcontrib><creatorcontrib>Sun, Maryellen</creatorcontrib><creatorcontrib>Yan, Kun</creatorcontrib><creatorcontrib>Yang, Wei</creatorcontrib><creatorcontrib>Li, Ji-You</creatorcontrib><title>Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Backoround Hepatocellular carcinoma (HCC) often occurs in association with liver cirrhosis. A stepwise carcinogenesis for HCC has been proposed. The purpose of this study was to observe the enhancement pattern of hepatocellular nodules in cirrhotic patients using contrast-enhanced ultrasound (CEUS) and to correlate patterns of enhancement at CEUS with the diagnosis of hepatocellular nodules using pathologic correlation as the gold standard. Methods Ninety-three cirrhotic patients with indeterminate hepatocellular nodules at ultrasound, underwent biopsy of each indeterminate nodule. Patients with nodules found to have pathologic diagnoses of regenerative nodules (RNs), dysplastic nodules (DNs), or DNs with focus of HCC (DN-HCC), were enrolled in this study. Enhancement patterns of all nodules were examined throughout the various vascular phases of CEUS and classified into five enhancement patterns: type I, isoenhancement to hepatic parenchyma at all phases; type II, hypoenhancement in the arterial phase, and isoenhancement in the portal venous phase and late phase; type III, iso-to-hypoenhancement in arterial and portal venous phase, and hypoenhancement in the late phase (washout); type IV, slight hyperenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout); and type V, partial hyperenhancement in the arterial phase and hypoenhancement in the late phase; and another partial iso-to-hypoenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout). The correlation between the contrast enhancement patterns and the pathological diagnoses was analyzed by the chi-squared test. Results Totally 132 lesions were examined with CEUS in 93 patients. Pathologic diagnoses included 45 DN, 68 RN, and 19 DN-HCC. The enhancement patterns observed were as follows: type I, 49 (37.1%); type II, 27 (20.5%); type III, 28 (21.2%); type IV, 9 (6.8%); type V, 19 (14.4%). Nodules with type I enhancement showed dysplasia in 5 (10.2%) cases; nodules with type II were dysplastic in 11 (40.7%) of cases; nodules with type III enhancement pattern were dysplastic in 22 (78.6%), and those with type IV enhancement contained dysplasia in 7 (77.8%) of cases. Type V enhancement corresponded to DN-HCC in 19 (100%) of cases. CEUS enhancement pattern was correlated with likelihood of dysplasia at pathologic analysis (Trend chi-square test, P 〈0.001). Pathological diagnosis was HCC in the enhanced area and hepatocyte dysplasia in the un-enhanced area in the 19 DN-HCC. Conclusion Pattern of enhancement at CEUS correlates with the pathologic diagnosis of hepatocellular nodules in liver cirrhosis, and may be helpful in predicting the progress from RN to HCC nodules.</description><subject>Adult</subject><subject>Aged</subject><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Contrast Media</subject><subject>Female</subject><subject>Humans</subject><subject>Image Enhancement</subject><subject>Liver Cirrhosis - complications</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Ultrasonography</subject><subject>卡方检验</subject><subject>增生性</subject><subject>病理诊断</subject><subject>肝癌</subject><subject>肝硬化</subject><subject>肝细胞癌</subject><subject>超声</subject><subject>造影</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNo90E1LwzAYB_AgipvTryD1Il5a89akOcrQKQy86LmkabKmrMlMWkU_vRlznh748-N5A-AOwYJwBu_VIIu-sDG6AhLGciaEKDBEuEC8gLg8AXNcUpyXjKJTMP83M3ARYw-TKDk7BzOMBcGoEnOwWno3BhnHXLtOOqXbbNruAz-5NvMm6_ROjl7JoKzzG-10tDGzLtvaTx0yZUPofIouwZmR26iv_uoCvD89vi2f8_Xr6mX5sM4VZtWYG8W54LwUBjdEU8oqrCppNGNt1VYcEVwyAaVpJNQaYsqNMJCiRmNDRArJAtwe-n5JZ6Tb1L2fgksT659ODf3-F4hDzBK8PsDd1Ay6rXfBDjJ818fTE7g5ANV5t_mwqdfRUIJEWpOSX-4xa7E</recordid><startdate>20120905</startdate><enddate>20120905</enddate><creator>Wu, Wei</creator><creator>Chen, Min-Hua</creator><creator>Sun, Maryellen</creator><creator>Yan, Kun</creator><creator>Yang, Wei</creator><creator>Li, Ji-You</creator><general>Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Ultrasound,Peking University Cancer Hospital & Institute,Beijing 100142,China%Abdominal Imaging,Department of Radiology,Beth Israel Deaconess Medical Center,Boston,02215,USA%Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Pathology,Peking University Cancer Hospital & Institute,Beijing 100142,China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20120905</creationdate><title>Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis</title><author>Wu, Wei ; Chen, Min-Hua ; Sun, Maryellen ; Yan, Kun ; Yang, Wei ; Li, Ji-You</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c268t-fc7797759f2b3e44682c8afe66d8d871325690afba0ee0247f9f041be2f39ba03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Contrast Media</topic><topic>Female</topic><topic>Humans</topic><topic>Image Enhancement</topic><topic>Liver Cirrhosis - complications</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Ultrasonography</topic><topic>卡方检验</topic><topic>增生性</topic><topic>病理诊断</topic><topic>肝癌</topic><topic>肝硬化</topic><topic>肝细胞癌</topic><topic>超声</topic><topic>造影</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Wei</creatorcontrib><creatorcontrib>Chen, Min-Hua</creatorcontrib><creatorcontrib>Sun, Maryellen</creatorcontrib><creatorcontrib>Yan, Kun</creatorcontrib><creatorcontrib>Yang, Wei</creatorcontrib><creatorcontrib>Li, Ji-You</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Wei</au><au>Chen, Min-Hua</au><au>Sun, Maryellen</au><au>Yan, Kun</au><au>Yang, Wei</au><au>Li, Ji-You</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2012-09-05</date><risdate>2012</risdate><volume>125</volume><issue>17</issue><spage>3104</spage><epage>3109</epage><pages>3104-3109</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Backoround Hepatocellular carcinoma (HCC) often occurs in association with liver cirrhosis. A stepwise carcinogenesis for HCC has been proposed. The purpose of this study was to observe the enhancement pattern of hepatocellular nodules in cirrhotic patients using contrast-enhanced ultrasound (CEUS) and to correlate patterns of enhancement at CEUS with the diagnosis of hepatocellular nodules using pathologic correlation as the gold standard. Methods Ninety-three cirrhotic patients with indeterminate hepatocellular nodules at ultrasound, underwent biopsy of each indeterminate nodule. Patients with nodules found to have pathologic diagnoses of regenerative nodules (RNs), dysplastic nodules (DNs), or DNs with focus of HCC (DN-HCC), were enrolled in this study. Enhancement patterns of all nodules were examined throughout the various vascular phases of CEUS and classified into five enhancement patterns: type I, isoenhancement to hepatic parenchyma at all phases; type II, hypoenhancement in the arterial phase, and isoenhancement in the portal venous phase and late phase; type III, iso-to-hypoenhancement in arterial and portal venous phase, and hypoenhancement in the late phase (washout); type IV, slight hyperenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout); and type V, partial hyperenhancement in the arterial phase and hypoenhancement in the late phase; and another partial iso-to-hypoenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout). The correlation between the contrast enhancement patterns and the pathological diagnoses was analyzed by the chi-squared test. Results Totally 132 lesions were examined with CEUS in 93 patients. Pathologic diagnoses included 45 DN, 68 RN, and 19 DN-HCC. The enhancement patterns observed were as follows: type I, 49 (37.1%); type II, 27 (20.5%); type III, 28 (21.2%); type IV, 9 (6.8%); type V, 19 (14.4%). Nodules with type I enhancement showed dysplasia in 5 (10.2%) cases; nodules with type II were dysplastic in 11 (40.7%) of cases; nodules with type III enhancement pattern were dysplastic in 22 (78.6%), and those with type IV enhancement contained dysplasia in 7 (77.8%) of cases. Type V enhancement corresponded to DN-HCC in 19 (100%) of cases. CEUS enhancement pattern was correlated with likelihood of dysplasia at pathologic analysis (Trend chi-square test, P 〈0.001). Pathological diagnosis was HCC in the enhanced area and hepatocyte dysplasia in the un-enhanced area in the 19 DN-HCC. Conclusion Pattern of enhancement at CEUS correlates with the pathologic diagnosis of hepatocellular nodules in liver cirrhosis, and may be helpful in predicting the progress from RN to HCC nodules.</abstract><cop>China</cop><pub>Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Ultrasound,Peking University Cancer Hospital & Institute,Beijing 100142,China%Abdominal Imaging,Department of Radiology,Beth Israel Deaconess Medical Center,Boston,02215,USA%Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Pathology,Peking University Cancer Hospital & Institute,Beijing 100142,China</pub><pmid>22932189</pmid><doi>10.3760/cma.j.issn.0366-6999.2012.17.025</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0366-6999 |
ispartof | Chinese medical journal, 2012-09, Vol.125 (17), p.3104-3109 |
issn | 0366-6999 2542-5641 |
language | eng |
recordid | cdi_wanfang_journals_zhcmj201217026 |
source | HEAL-Link subscriptions: Lippincott Williams & Wilkins |
subjects | Adult Aged Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - pathology Contrast Media Female Humans Image Enhancement Liver Cirrhosis - complications Liver Neoplasms - diagnostic imaging Liver Neoplasms - pathology Male Middle Aged Ultrasonography 卡方检验 增生性 病理诊断 肝癌 肝硬化 肝细胞癌 超声 造影 |
title | Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A40%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contrast-enhanced%20ultrasound%20of%20hepatocarcinogenesis%20in%20liver%20cirrhosis&rft.jtitle=Chinese%20medical%20journal&rft.au=Wu,%20Wei&rft.date=2012-09-05&rft.volume=125&rft.issue=17&rft.spage=3104&rft.epage=3109&rft.pages=3104-3109&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.3760/cma.j.issn.0366-6999.2012.17.025&rft_dat=%3Cwanfang_jour_pubme%3Ezhcmj201217026%3C/wanfang_jour_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c268t-fc7797759f2b3e44682c8afe66d8d871325690afba0ee0247f9f041be2f39ba03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/22932189&rft_cqvip_id=43197974&rft_wanfj_id=zhcmj201217026&rfr_iscdi=true |